01
Convene
Bring researchers, parliamentarians, regulators, professional bodies and patient advocates into House of Commons
The AMR Interface
Turning AMR evidence intoparliamentary action
An researcher-led standing channel between antimicrobial resistance research, the UK Parliament, and the systems where policy becomes practice.
Convening evidence.
Translating policy.Driving implementation.
20+Senior stakeholders
5Actionable recommendations
4Outputs per cycle
May 2026AMR Parliamentary Roundtable
The UK's AMR challenge is no longer one of evidence —
but of translation.
Antimicrobial resistance is one of the best-evidenced threats in UK health policy. The research exists. The National Action Plan exists. What has been suggested is a standing mechanism that carries findings into Parliament, converts them into decisions, and follow-up implementation
The AMR Interface is that mechanism — designed to translate AMR research into Parliamentary Conversation
Built on written evidence submitted to the Public Accounts Committee AMR inquiry, and on the accountability gap the Committee identified in 2025.
How the AMR Interface works
Convene · Translate · Account
Three functions, on a fixed rhythm, complementing each other, to support the future of AMR in the UK
02
Translate
Convert convergent evidence into concrete recommendations for the UK National Action Plan, supported by measurable indicator.
03
Account
Translate research into actionable recommendations for stewardship implementation to confront AMR, and closing the loop the Public Accounts Committee inquiry
The AMR Translation Cycle
A replicable six-stage method and the operational backbone of the Interface. Every stage produces a citable artefact, and every cycle feeds the next.
- Stage 1
Listen
Scan the evidence base, live inquiries and lived experience to set the agenda.
- Stage 2
Convene
Put research, Parliament, regulators and patients at one table at House of Commons
- Stage 3
Distil
Co-create recommendations in the room, with multi-stakholders
- Stage 4
Publish
Issue the policy brief and the peer-reviewed record of the method.
- Stage 5
Uptake
Track citation, adoption and alignment with the National Action Plan.
- Stage 6
Account
Return to Parliament and report, and disseminate the Policy Brief recommendations
The cycle is designed to share latest AMR/AMS research with members of parliament and stakholders
Explore the Translation CycleAt House of Commens, Westminster
AMR Parliamentary Roundtable
Two hours, in Westminster, was scheduled with MPs champions
May 2026Completed
Translating AMR Research into Parliamentary Action
House of Commons. Hosted by Andrew Lewin MP and Baroness Bennett of Manor Castle, MPs and Lords, chaired by Professor Sam Salek, conveyed by Dr Rasha Elshenawy. Five recommendations, four outputs.
View roundtable →
June 2026Policy Brief Published
Translating AMR Research into Parliamentary Action
Implementation, not evidence: priorities for the next UK National Action Plan on Antimicrobial Resistance
Propose a topic →
Published Outputs
Policy briefs, reports & publication
Everything the Interface produces is public, dated and citable.
The patient voice
You cannot create policies for patients without working with the people who are affected. There is nothing about us without us.
Vanessa CarterAMR survivor · Founder, The AMR Narrative · Chair, WHO Task Force of AMR Survivors
Find your route in
Parliamentary & policy staff
Brief us, or be briefed
Request a briefing, table a question, or invite us to give evidence to a Select Committee.
Get in touch →
Researchers
Submit evidence
Propose a roundtable topic, send a written reflection, or co-author the methodology paper.
Submit →
Patients & advocates
Share your voice
Contribute lived experience or join the standing patient and public involvement panel.
Share →
Public & press
Register for outputs
Receive each policy brief and the quarterly update on AMR and Parliament.
Register →
Get involved
Register your interest to receive the call for reflections and the policy brief that follows the next roundtable.